Orchestra BioMed Holdings (OBIO) Receivables (2022 - 2025)
Historic Receivables for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $52000.0.
- Orchestra BioMed Holdings' Receivables fell 5478.26% to $52000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $52000.0, marking a year-over-year decrease of 5478.26%. This contributed to the annual value of $92000.0 for FY2024, which is 707.07% down from last year.
- According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Receivables is $52000.0, which was down 5478.26% from $83000.0 recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Receivables ranged from a high of $171000.0 in Q2 2023 and a low of $52000.0 during Q3 2025
- Moreover, its 4-year median value for Receivables was $87500.0 (2023), whereas its average is $92166.7.
- As far as peak fluctuations go, Orchestra BioMed Holdings' Receivables soared by 3372.09% in 2024, and later crashed by 5478.26% in 2025.
- Orchestra BioMed Holdings' Receivables (Quarter) stood at $96000.0 in 2022, then rose by 3.12% to $99000.0 in 2023, then fell by 7.07% to $92000.0 in 2024, then crashed by 43.48% to $52000.0 in 2025.
- Its last three reported values are $52000.0 in Q3 2025, $83000.0 for Q2 2025, and $89000.0 during Q1 2025.